8-117830205-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000127.3(EXT1):c.1284+25G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,570 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00013   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.000060   (  1   hom.  ) 
Consequence
 EXT1
NM_000127.3 intron
NM_000127.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.0900  
Publications
0 publications found 
Genes affected
 EXT1  (HGNC:3512):  (exostosin glycosyltransferase 1) This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008] 
EXT1 Gene-Disease associations (from GenCC):
- exostoses, multiple, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- chondrosarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 8-117830205-C-T is Benign according to our data. Variant chr8-117830205-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 255171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000131 (20/152206) while in subpopulation AMR AF = 0.00085 (13/15286). AF 95% confidence interval is 0.000503. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. 
BS2
High AC in GnomAd4 at 20 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| EXT1 | ENST00000378204.7 | c.1284+25G>A | intron_variant | Intron 4 of 10 | 1 | NM_000127.3 | ENSP00000367446.3 | |||
| EXT1 | ENST00000436216.2 | n.*85+25G>A | intron_variant | Intron 5 of 5 | 3 | ENSP00000400372.1 | ||||
| EXT1 | ENST00000437196.1 | n.*175+25G>A | intron_variant | Intron 3 of 9 | 5 | ENSP00000407299.1 | ||||
| EXT1 | ENST00000684189.1 | n.751+25G>A | intron_variant | Intron 4 of 10 | 
Frequencies
GnomAD3 genomes  0.000132  AC: 20AN: 152088Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
20
AN: 
152088
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000128  AC: 32AN: 250942 AF XY:  0.000155   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
32
AN: 
250942
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000595  AC: 87AN: 1461364Hom.:  1  Cov.: 31 AF XY:  0.0000729  AC XY: 53AN XY: 727000 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
87
AN: 
1461364
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
53
AN XY: 
727000
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33478
American (AMR) 
 AF: 
AC: 
11
AN: 
44714
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3
AN: 
26130
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39660
South Asian (SAS) 
 AF: 
AC: 
19
AN: 
86238
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53160
Middle Eastern (MID) 
 AF: 
AC: 
5
AN: 
5760
European-Non Finnish (NFE) 
 AF: 
AC: 
39
AN: 
1111844
Other (OTH) 
 AF: 
AC: 
10
AN: 
60380
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.453 
Heterozygous variant carriers
 0 
 5 
 10 
 15 
 20 
 25 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000131  AC: 20AN: 152206Hom.:  0  Cov.: 31 AF XY:  0.000148  AC XY: 11AN XY: 74404 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
20
AN: 
152206
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
11
AN XY: 
74404
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41536
American (AMR) 
 AF: 
AC: 
13
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4806
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10612
Middle Eastern (MID) 
 AF: 
AC: 
4
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3
AN: 
68012
Other (OTH) 
 AF: 
AC: 
0
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.470 
Heterozygous variant carriers
 0 
 2 
 3 
 5 
 6 
 8 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Exostoses, multiple, type 1    Benign:1 
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.